DermaSensor, Inc.

DermaSensor, Inc. develops a handheld, AI-enabled device that helps physicians assess suspicious skin lesions at the point of care. The device combines elastic scattering spectroscopy with a machine-learning algorithm to support evaluation of lesions associated with melanoma, basal cell carcinoma, and squamous cell carcinoma. The company also provides clinician training, patient education, customer support, software and device services, and reimbursement guidance for healthcare providers.